Table 1.
Characteristic | Value |
---|---|
Median age (range), y | 63 (26-71) |
Sex, female/male, n | 7/6 |
Diagnosis, n | |
Acute myeloid leukemia | 4 |
Myelodysplastic syndrome | 3 |
Non-Hodgkin lymphoma | 3 |
Myeloproliferative disorder | 1 |
Chronic lymphocytic leukemia | 1 |
Myelofibrosis | 1 |
Graft source, n | |
Peripheral blood stem cells | 12 |
Bone marrow | 1 |
Donor, n | |
Matched unrelated | 9 |
Matched related | 2 |
Haploidentical | 2 |
Conditioning, n | |
Reduced intensity | 10 |
Myeloablative | 3 |
GVHD prophylaxis, n | |
Tacrolimus/sirolimus | 9 |
Tacrolimus/methotrexate | 2 |
Posttransplant cyclophosphamide plus tacrolimus/mycophenolate mofetil | 2 |